UNSPSC 85513858: Dilation of right internal iliac artery with drug-eluting intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of right internal iliac artery with drug-eluting intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 047E44Z

UNSPSC 85513858 Dilation of right internal iliac artery with drug-eluting intraluminal device, percutaneous endoscopic approach is a Commodity code that shows a fundamental mismatch between its clinical procedural title and the scope of recent state and local contract opportunities posted under it. The code's nominal name describes a specific interventional vascular procedure, yet the recent opportunities solicited under this code address occupational health surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, and surgical care networks — none of which involve percutaneous iliac artery dilation. State and local procurement offices have tagged these opportunities with this code despite their unrelated clinical and operational scope, suggesting either a cataloging error or a broad misapplication of the code across medical service categories that do not align with the code's actual procedural definition. This mismatch severely limits the code's utility as a reliable indicator of procurement intent in this taxonomy tier.

The recent opportunities do reveal active state and local buying across multiple jurisdictions and issuing body types, including a city pension board (Phoenix), a municipal HR department (Long Beach), a state transportation agency (Washington State Department of Transportation), a county probation authority (Harris County), a county health system (Santa Clara), and a county board of commissioners (Collier County). However, these opportunities represent general health services procurement — medical staffing, benefits administration, occupational health, and specialty care networks — rather than the Commodity code's stated procedural scope. Geographic spread spans Arizona, California, Florida, and Washington, with activity posted between July and September 2026. Without a reliable connection between the code's clinical definition and current purchasing activity, business development professionals should treat this code as unreliable for targeting state and local procurement in medical devices, vascular interventions, or related procedural categories, and instead monitor issuing bodies and service categories directly.